Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of EVT-401 plus methotrexate in active rheumatoid arthritis with inadequate methotrexate response
CTR20253606Phase 2Active
- Sponsor
- Zhejiang Jinhua CONBA Bio-Pharm
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of EVT 401 in rheumatoid arthritis (RA), sponsored by Zhejiang Jinhua CONBA Bio-Pharm. Started Oct 2025; status: active.
02
Drugs
EVT 401
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20253606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253606.